 |
Tony Fong is senior editor for GenomeWeb Daily News, tracking the firms that compete in the genomics tools and molecular diagnostics industries. E-mail Tony Fong or follow GWDN's headlines at @DailyNewsGW. |
Sequenom's CEO 'Puzzled' by Illumina's Buy of Verinata, Lays out 2013 Goals at JP Morgan
January 10, 2013
Sequenom's CEO 'Puzzled' by Illumina's Buy of Verinata, Lays out 2013 Goals at JP Morgan
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Following Verinata Acquisition, Illumina Plans to Submit Prenatal Test to FDA as IVD Product
January 9, 2013 / Clinical Sequencing News - Illumina to Acquire Verinata for up to $450M
January 7, 2013 / GenomeWeb Daily News - Prenatal Sequencing Becoming Standard of Care in Increasingly Litigious Market
January 16, 2013 / Clinical Sequencing News - PerkinElmer to Market Verinata's Noninvasive Prenatal Trisomy Test
January 9, 2013 / GenomeWeb Daily News - Sequenom Collects 18K Samples for MaterniT21 Plus in Q3, Expects to Bill for Over 50K Tests in 2012
November 14, 2012 / Clinical Sequencing News